Deadlines
Letter of Intent: 6/1/2023
Submission: 10/5/2023
Overview
The Translational Research Acceleration Program (TRAP) awards will accelerate the movement of preclinical research toward an Investigational New Drug filing and into clinical trials to provide a robust and diverse pipeline of potential therapies to fight inherited retinal degenerations (IRD) and dry age-related macular degeneration.
For more information, please see the Foundation’s website.